Doxefazepam: Difference between revisions
From Drugwiki
m 1 revision imported |
m 1 revision imported |
(No difference)
| |
Latest revision as of 15:18, 29 October 2025
Doxefazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. According to Babbini and colleagues in 1975, this derivative of flurazepam was between 2 and 4 times more potent than the latter while at the same time being half as toxic.
| |
Doxefazepam
| |
| Systematic (IUPAC) name | |
| 9-chloro-6-(2-fluorophenyl)-4-hydroxy -2-(2-hydroxyethyl)-2,5-diazabicyclo [5.4.0]undeca-5,8,10,12-tetraen-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H14ClFN2O3 |
| Mol. mass | 348.8 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | 3-4 hours[1] |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Brand names
- Doxans
